Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Staar Promotes Visian ICL For Myopia As Cataract Sales Decline

This article was originally published in The Gray Sheet

Executive Summary

A successful rollout of Staar Surgical's recently FDA-approved Visian implantable contact lens (ICL) nearly offset steadily declining sales of its cataract products during the first quarter
Advertisement

Related Content

People In Brief
People In Brief
FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
Advertisement
UsernamePublicRestriction

Register

MT023530

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel